Anavex Life Sciences Corp (AVXL)

[Investor2014]

The lead plaintiff in a securities class action case doesn’t get preferential treatment on the damages that can be claimed. All damaged investors claim according the same plan of allocation issues for a settled case.

The only, risky and expensive way for a large investor to potentially claim more is to opt out and run a separate parallel case based on a different damages model.